726 MIYAZAKI A et al. Circ J 2017; 81: ORIGINAL ARTICLE doi: /circj.CJ

Size: px
Start display at page:

Download "726 MIYAZAKI A et al. Circ J 2017; 81: ORIGINAL ARTICLE doi: /circj.CJ"

Transcription

1 726 MIYAZAKI A et al. Circ J 2017; 81: ORIGINAL ARTICLE doi: /circj.CJ Pediatric Cardiology and Adult Congenital Heart Disease Mid-Term Follow-up of School-Aged Children With Borderline Long QT Interval Aya Miyazaki, MD; Heima Sakaguchi, MD; Yu Matsumura, MD; Yosuke Hayama, MD; Kanae Noritake, MD; Jun Negishi, MD; Etsuko Tsuda, MD; Yoshihiro Miyamoto, MD; Takeshi Aiba, MD; Wataru Shimizu, MD; Kengo Kusano, MD; Isao Shiraishi, MD; Hideo Ohuchi, MD Background: There are no definitive diagnostic criteria or follow-up strategies for long QT syndrome (LQTS) in children with a borderline long QT interval (b-lqt). Methods and Results: We retrospectively evaluated the clinical course, genetic testing results, corrected QT interval (QTc), and LQTS score of 59 school-aged children (5 18 years old) with a b-lqt (400 QTc<500 ms). Syncope, but neither aborted cardiac arrest nor sudden cardiac death, occurred in 2 patients during the follow-up (6±3.4 years) with LQTS scores 4.5 points. The genetic testing results were positive in 92%, 57%, and 67% of patients with high, intermediate, and low probabilities of LQTS, respectively. The maximum and mean QTc during the follow-up significantly differed among the categories with a probability of LQTS, but not the minimum QTc. However, the QTc at rest and at the recovery point after exercise stress testing dramatically changed at the last followup. Consequently, the probability of LQTS changed in half of the patients. Conclusions: The LQTS score is a reasonable indicator for evaluating school-aged children with a b-lqt, and patients with a low LQTS score appear to be at low risk for cardiac events. However, the LQTS score can change during follow-up. Therefore, when there is doubt or concern for patients with a b-lqt, it is preferable to continue following them. Guidelines on follow-up strategies are desired for b-lqt. Key Words: Borderline long QT interval; Long QT syndrome; LQTS score; Mid-term follow-up; Schoolchildren Recently, the probability of a diagnosis of long QT syndrome (LQTS) was reported to be 1:3,298 in children aged 6 years and 1:988 in children aged 12 years based on the ECG school screening program in Japan. 1 Another study reported a high estimated probability of an aborted cardiac arrest (ACA) or sudden cardiac death (SCD) in school-aged children with LQTS, especially in boys with a corrected QT interval (QTc) 500 ms. 2 In the international LQTS registry study, the 5-year cumulative probability of ACA or SCD in children and adolescents with a QTc <500 ms with and without a history of syncope was reported to be 11% and 1%, respectively. 3 However, there are no recognized definitions of the upper and lower limits of a normal QT interval. The distribution of the QTc in the normal population and in individuals with LQTS overlaps between 400 and 500 ms. 4 The QTc values of the majority of the general population fall within Editorial p 640 a range of ms, during which LQTS remains possible. Despite comprehensive genetic testing of the currently known genes, approximately 15 20% of LQTS remains genetically elusive. 5 In a review of channelopathies published in 2013, 6 the considerable problems related to genetic testing were described as follows: For a patient who presents with a marginal phenotype, a positive genetic test, indicating a genetic variant, may not mean that they have the disease. Worse, there are patients who have a clear clinical phenotype and have a mutation, but the mutation is not linked to the disease. Instead, it may just be a normal variation, inconveniently residing as a bystander in the genome of a patient with that phenotype. Received September 29, 2016; revised manuscript received January 6, 2017; accepted January 12, 2017; released online February 18, 2017 Time for primary review: 18 days Department of Pediatric Cardiology (A.M., H.S., Y. Matsumura, Y.H., K.N., J.N., E.T., I.S., H.O.), Department of Cardiovascular Medicine, Division of Arrhythmias and Electrophysiology (T.A., W.S., K.K.), Department of Preventive Cardiology (Y. Miyamoto), Department of Preventive Medicine and Epidemiologic Informatics (Y. Miyamoto), National Cerebral and Cardiovascular Center, Suita; Department of Cardiovascular Medicine, Graduate School of Medicine, Nippon Medical School, Tokyo (W.S.), Japan Mailing address: Aya Miyazaki, MD, Department of Pediatric Cardiology, National Cerebral and Cardiovascular Center, Fujishirodai, Suita , Japan. ayamiya@ncvc.go.jp ISSN All rights are reserved to the Japanese Circulation Society. For permissions, please cj@j-circ.or.jp

2 Schoolchildren With b-lqt 727 Genetic testing in asymptomatic patients with a borderline LQT interval (b-lqt) seems to have less diagnostic significance than in symptomatic patients. Thus, there are no definitive diagnostic criteria for LQTS in patients with b-lqt, and it is unclear whether follow-up is necessary. However, among children with b-lqt, some have LQTS and are at risk of SCD, and their identification is critical. Therefore, in this study, we retrospectively evaluated the clinical characteristics of school-aged children with a b-lqt (400 QTc<500 ms) to determine the appropriate follow-up strategy. We assessed the following issues: clinical course during a mid-term follow-up; genetic testing results; and changes in the QTc and LQTS score during the follow-up. for a long QT interval. The authors assert that all procedures related to this work complied with the relevant national guidelines on human experimentation (Japan) and with the Declaration of Helsinki of 1975 (as revised in 2008), and were approved by the institutional ethics committees (Reference no. M28 019). Clinical Characteristics The following parameters were assessed: sex; age at the initial presentation; reason for the initial presentation; a family history of LQTS; genetic testing results; LQTS score at the initial presentation and at the end of the follow-up; ECG findings at the initial presentation, during Methods Patients The 122 consecutive pediatric patients were followed from February 1994 to April 2016 because they had prolonged QT interval. The patients who presented only once, and in whom the physician denied the possibility of LQTS and judged no necessity for follow-up, were excluded. The age distribution and reasons for the initial presentation of all patients are shown in Figure 1. We excluded 36 patients aged <5 years from this study, because an exercise tolerance test was unavailable in this age group and they presented at the hospital mainly because of a family history or symptoms. Moreover, 26 patients with a QTc 500 ms and who had already received medication were excluded to eliminate any factors unrelated to b-lqt. In total, b-lqt was retrospectively evaluated in 59 patients aged 5 years with a QTc 400 ms and <500 ms and without medication Figure 1. Age distribution and reasons for the initial presentation of all pediatric patients with borderline long QT interval. The 36 patients aged <5 years old were presented at the hospital mainly because of a family history (Fx) or symptoms. Table. Pediatric Patients Characteristics According to the Probability of Long QT Syndrome Based on the Long QT Syndrome Score Total High probability (LQTS score 3.5 points) Intermediate probability (LQTS score points) Low probability (LQTS score 1 point) P value n Age at the initial presentation (years) (12.4) (12.6) (12.2) (9.7) NS Reason for the initial presentation (#) School screening 48 (81%) 17 (85%) 24 (83%) 7 (70%) Family history of LQTS 6 (10%) 1 (5%) 3 (10%) 2 (20%) Symptoms 5 (8%) 2 (10%) 2 (7%) 1 (10%) Sex (M:F) 22:37 7:13 12:17 3:7 Family history of LQTS at the initial presentation (#) ECG findings at the initial presentation QTc (ms) 471± (487) (470) (451) < Resting heart rate (beats/min) 77±13 72±13 79±12 81±17 NS Notched T-wave in 3 leads (#) 0 Follow-up period (years) 6± ± ± ±4.0 NS Family history of LQTS at the last follow-up (#) Medication during follow-up (#) Follow-up period in the patients 6.1± ± ± ±4.5 NS without medication (years) (n=48) No. of resting ECGs during the follow-up in the patients without medication 16±9 16±8 17±9 15±11 NS LQTS, long QT syndrome; QTc, QT interval corrected using Bazett s formula. 12

3 728 MIYAZAKI A et al. Figure 2. Relationship between the long QT syndrome score at the initial presentation and a history of syncope/convulsions at the initial presentation (A) and cardiac events during the follow-up (B). The follow-up period was 6±3.4 years in 59 patients. No aborted cardiac arrests were observed, but new syncopal events occurred in 1 patient and convulsions in another. Convulsions in patients with a low probability of long QT syndrome were most likely clinically unrelated to cardiac arrhythmias. Hx, history. Figure 3. Results of genetic testing. (A) Relationship between the long QT syndrome (LQTS) score at the initial presentation and the results of genetic testing. (B) Ratio of a positive genetic test in patients with a high, intermediate, or low probability of LQTS. RyR2, ryanodine receptor gene. follow-up, and at the end of the follow-up; findings of the treadmill-based exercise stress test, cardiac events or convulsions before the initial presentation and during the follow-up; and medical treatments for long QT interval. The symptoms that prompted the initial presentation included chest pain, convulsions, and syncope. The LQTS score was calculated based on the criteria published by Schwartz and Crotti in A criterion referred to by the original LQTS score 8,9 was used for a low heart rate according to age (resting heart rate below the second percentile for age). The LQTS score at the initial presentation was retrieved from the data collected during the examination conducted at the initial presentation. At that time, family members who were not diagnosed with LQTS were not counted as LQTS family members. At the end of the follow-up, the QTc and LQTS score were only evaluated in the patients who were followed without any medication for QT prolongation. The latest ECG findings and results of the exercise stress test were used at the end of the follow-up. A history of syncope and family history of LQTS were updated during the follow-up. The categories of the probability of LQTS were the same as those used by Schwartz and Crotti: 7 low probability of LQTS represented 1 point, an intermediate probability points, and a high probability 3.5 points. Measurement of the QT Interval The QT interval was measured manually using the tangent method in lead V5 or V6 at rest and at the 4-min recovery point after the exercise stress test. 10,11 Subsequently, the QTc values were calculated using Bazett s formula. 12 In the case of sinus arrhythmia, the QT interval immediately following the shortest RR interval was used. 13 School Screening Program for Heart Diseases in Japan In Japan, there is a nationwide school-based ECG screen- Figure 4. Comparisons of the maximum (A), minimum (B), and mean (C) corrected QT (QTc) intervals during the followup between a high, intermediate, and low probability of LQTS in 48 patients without medication. The maximum and mean QTc intervals significantly differed between a high, intermediate, and low probability of LQTS; however, the minimum QTc did not differ. Open circle=non-genotyped patients; red, yellow, and orange diamonds=qtc in the patients with LQT1, LQT2, and LQT3, respectively.

4 Schoolchildren With b-lqt 729 Figure 5. Changes in the corrected QT (QTc) interval at rest (A) and at the 4-min recovery point after the exercise stress test (B) between the initial presentation and last follow-up in patients with a high, intermediate, and low probability of long QT syndrome. The QTc at rest was evaluated in 48 patients without medication during the follow-up (6.1±3.6 years). The QTc at the 4-min recovery point after the exercise stress test was evaluated in 32 patients who underwent the exercise stress test more than twice without medication (time between the initial and last exercise stress tests: 5.9±3.0 years). Open circle=non-genotyped patients; red, yellow, and orange diamonds=qtc in the patients with LQT1, LQT2, and LQT3, respectively. ing program for heart diseases for all 1st, 7th, and 10th graders (6 7, and years old). 1,10 This system consists of 3 steps. First, a standard 12-lead ECG is performed, and the children complete a questionnaire to determine any history of cardiac symptoms or a family history of SCD. Children with abnormal ECG findings and abnormal clinical and familial findings proceed to the second step of the examination. When the children are suspected of having cardiac problems, they are referred to a hospital for a more detailed examination. In this program, the detection range for a long QT interval is a QTc 450 ms at a heart rate <75 beats/min and 500 ms at a heart rate 75 beats/min. Also, the age- and sex-specific criteria using Fridericia s formula 14 are evaluated. The 10th graders (15 16 years old) generally visit the adult cardiology department, because the upper age limit for the atten- dance of pediatric departments in Japan is 15 years old. In this study, when patients visited hospital because of the school screening system, the ECGs obtained during the school screening were used as the ones for the initial presentation. Genetic Testing Although information on genetic testing was given to all patients, the genetic analysis was only performed in patients who consented. Patients with syncopal episodes, a family history of LQTS, or a QTc at rest 500 ms during the follow-up were strongly recommended to undergo genetic testing. The protocol for the genetic analysis was approved by the institutional ethics committee (Reference no. M ) and performed under its guidelines. Genomic

5 730 MIYAZAKI A et al. Figure 6. Changes in the long QT syndrome score (A) and probability of long QT syndrome (B,C) during the follow-up period in 48 patients without medication. The follow-up period was 6.1±3.6 years in 48 patients without medication. Open circle=nongenotyped patients. In (A), the red, yellow, and orange diamonds=the score in patients with LQT1, LQT2, and LQT3, respectively. Probability of long QT syndrome in 31 females (B) and in 17 males (C). DNA was isolated from whole blood using a DNA analyzer (QIAGEN GmbH, Hilden, Germany). 15 Genetic screening for mutations in the KCNQ1, KCNH2, and SCN5A (and, if necessary, KCNE1, KCNE2, and KCNJ2) genes was performed by direct sequencing (ABI 3730 DNA Analyzer; Life Technologies, Carlsbad, CA, USA). The cdna sequence numbering was based on the GenBank reference sequence. One patient in whom no mutations of KCNQ1, KCNH2, and SCN5A were detected underwent a whole-exon sequencing analysis to identify all the mutations in the known LQTS and candidate genes. 16 The captured DNA was sequenced using the HiSeq TM 2000 (Illumina, San Diego, CA, USA), as described previously. 17 As a result, a rare variant in the cardiac ryanodine receptor gene was detected. We enrolled this patient in the current study, because her ECG had a b-lqt and we followed her as a case of LQTS. We considered the mutations for which a link with LQTS has already been established in previous publications as disease-causing. In the absence of references, novel variants were included when they were deemed to be pathogenic or likely pathogenic by applying the recently published ACMG guidelines, 18 which are based on criteria using typical types of variant evidence, including the frequencies in the population data and computational (in silico) predictive programs. 19 Statistical Analysis Data are presented as the mean ± standard deviation or median (range) as appropriate, depending on their distribution (Shapiro-Wilk test), using JMP version 11 software (SAS Institute Inc., Cary, NC, USA). A two-tailed unpaired Student s t-test or Wilcoxon signed-rank sum test was used to compare the patient characteristics and the QTc among the categories of a probability of LQTS, as appropriate. A two-tailed paired t-test was used to com- pare the QTc and LQTS score during the follow-up. However, a statistical analysis was not performed to compare the cardiac events during the follow-up and a genetic analysis, because of the small population size. Results Clinical Characteristics at the Initial Presentation The age at the initial presentations of the 59 patients aged 5 years with a QTc 400 ms and <500 ms was 12.3 (range: ) years (male to female ratio 22:37).The reason for the initial presentation was a school screening in 48 patients (81%), family history of LQTS in 6 (10%), and symptoms in 5 (9%). The symptoms as the reason for the initial presentation included chest pain in 2 patients, syncope in 2, and convulsions in 1. The QTc on the resting ECG was 471±18 ms, and the LQTS score was 3 (range: 0 6.5) points. Based on the LQTS score, a high probability of LQTS (LQTS score 3.5 points) was evident in 20 patients (34%), an intermediate probability (1.5 3 points) in 29 (49%), and a low probability ( 1 point) in 10 (17%). The patients characteristics according to the probability of LQTS and the detailed characteristics in each patient are shown in Table and Table S1, respectively. There were 4 patients with a high or intermediate probability of LQTS who had a history of syncope; 2 with an intermediate or low probability of LQTS had a history of convulsions (Figure 2A); and 6 patients (10%) had a family history of LQTS. Clinical Course During the Follow-up During the follow-up period (6±3.4 years), no cases of ACA or SCD were observed, but syncope occurred in 2 patients with an LQTS score 4.5 points (Figure 2B). Convulsions occurred in 2 patients with an LQTS 1 point, but were most likely clinically unrelated to cardiac

6 Schoolchildren With b-lqt 731 arrhythmias. β-blockers were administrated to 11 patients (propranolol in 6 and bisoprolol in 5) after the initial presentation, for syncope in 4 patients, a prolonged QTc in 3, ventricular tachyarrhythmias during the epinephrine loading test or exercise stress test in 3, and convulsions of unknown etiology in one. One patient with a history of syncope and an LQTS score of 3 was not treated, because the syncopal episode was strongly suspected to have a neurologic origin. Genetic Characteristics Genetic tests were performed in 31 patients (54%) and the results are shown in Figure 3. Genetic mutations related to LQTS were detected in 11 (92%) of 12 patients with a high probability of LQTS, in 8 (57%) of 14 patients with an intermediate probability of LQTS, and in 4 (67%) of 6 patients with a low probability of LQTS. Changes in QTc Interval and LQTS Score in 48 Patients Without Medication During the Follow-up Among the 48 patients not receiving medication, a total of 777 ECGs were evaluated (16±9 per patient) during the follow-up period (6.1±3.6 years). The maximum and mean QTc during the follow-up significantly differed among the categories with a probability of LQTS, but not the minimum QTc (Figure 4). The QTc at rest changed dramatically by the last followup, albeit, there were no statistical differences (Figure 5A). Regarding the QTc at the 4-min recovery point after the exercise stress test, a dramatic change was also observed in 32 patients who underwent an exercise stress test without medication (time between the initial and last exercise stress tests: 5.9±3.0 years; Figure 5B). Consequently, the LQTS score also changed during the follow-up (Figure 6A). The categories of the probability of LQTS at the last follow-up remained the same as at the initial presentation in 23 of 48 patients without medication (48% of the total). In the other 25 (52%) patients, it changed between the initial presentation and last follow-up (Figure 6B). In females, it changed from a high to an intermediate probability in 2 of 10 patients (20%), and to a low probability in 1 (10%). Among the 16 patients with an intermediate probability of LQTS, it changed to a high probability in 5 (31%), and to a low probability in 8 (50%). In one of 5 patients (20%) with a low probability of LQTS it changed to a high probability and in one to an intermediate probability. In males, it changed from a high to an intermediate probability in 3 of 4 patients (75%). Among the 10 patients with an intermediate probability of LQTS, it changed to a high probability in 1 patient (10%) and to a low probability in 3 (30%). Discussion We examined the clinical characteristics of 59 school-aged children with a b-lqt (400 QTc<500 ms) who were suspected of having LQTS. No cases of ACA or SCD were observed, but syncope occurred in 2 patients with a high probability of LQTS during the mid-term follow-up. The genetic test was positive in 92%, 57%, and 67% of the patients with a high, intermediate, and low probability of LQTS, respectively. The maximum and mean QTc during the follow-up significantly differed among the categories with a probability of LQTS, but not the minimum QTc. The QTc at rest and at the 4-min recovery point after the exercise stress test dramatically changed between the initial presentation and the last follow-up. Consequently, the categories of the probability of LQTS changed by the last follow-up in half of the patients who were followed without meditation. Definition and Incidence of b-lqt The definition of a b-lqt varies greatly among the published studies. In a study by Viskin, the QTc values of a b-lqt were defined as ms for males and ms for females. 4 In the expert consensus statement of the Heart Rhythm Society, European Heart Rhythm Association, and Asia Pacific Heart Rhythm Society, it was stated that patients with a QTc of ms can only be diagnosed when they have a history of syncope. 20 Therefore, according to that statement, a b-lqt corresponds to a QTc of ms without unexpected syncope and <480 ms with or without syncope. In a study of an exercise-based algorithm for the prediction of LQTS published in 2011, a b-lqt was defined as a QTc of ms in males and ms in females. 11 In the nationwide school-based ECG screening program in Japan, a b-lqt is defined as a QTc 450 ms at a heart rate <75 beats/min, and 500 ms at a heart rate 75 beats/min. 1,10 It is difficult to determine the incidence of b-lqt because there is no agreed upon definition of the condition. However, in a school-based ECG screening program conducted in Kanazawa, Japan, the prevalence of a long QT interval ( 450 ms for boys and 460 ms for girls) in 7,961 schoolchildren was 1.1% in boys and 0.5% in girls. Among those 71 children with a long QT interval, 85% had an LQTS score 1 point. 21 In another study of the prevalence of a long QT interval as identified by the school-based screening program in Kagoshima, Japan, it was present in 0.2% of 32,982 1st graders (6 7 years old) and 0.3% of 34,572 7th graders. 1 Patients with a QTc 500 ms are diagnosed with LQTS in many studies, but the lower range of the QTc for b-lqt remains unclear. In this study, we defined patients with a QTc 400 ms and <500 ms as having b-lqt. We included patients with a QTc 400 ms and <450 ms who were suspected to have LQTS, because some of them had LQTS genes and some of them a prolonged QTc during the follow-up (Table S1). Methods of Evaluating b-lqt To date, there are 3 main methods of evaluating b-lqt: exercise stress test, epinephrine test, and LQTS score. 7,11,22 Among these, the LQTS score appears to be more useful and better suited for use in clinical situations, because it incorporates symptoms, family history, and the results from the exercise stress test. In this study, we evaluated school-aged children with b-lqt based on their LQTS score. During the follow-up period, syncope only occurred in patients with a high probability of LQTS based on the LQTS score. A positive genetic test occurred in 92% of patients with a high probability of LQTS, but in only 57% and 67% of those with an intermediate and low probability of LQTS, respectively. However, in half of the patients, the categorization of the probability of LQTS changed at final follow-up. The LQTS score is a reasonable method to detect LQTS among school-aged children with b-lqt, but we should recognize that it is not the perfect method.

7 732 MIYAZAKI A et al. Follow-up Strategy for b-lqt Our results indicated the arduousness of identifying LQTS from b-lqts by a 1-point evaluation. As it stands, when there is doubt or concern about patients with b-lqt, it is preferable to continue following them, because the cumulative rate of ACA or SCD is reported to be around 1 2% at 13 years old in children with a QTc <500 ms. 2 We propose that follow-up of patients with b-lqt exhibiting an intermediate or high probability of LQTS at the initial presentation and during the follow-up should be continued. Even in patients with a low probability of LQTS we would perform repeated ECGs, because some of them may show a prolonged QT interval during the follow-up. Study Limitations First, the sample size was small and the event rate was low. Second, this study retrospectively evaluated patients subject to sample selection bias, that is, the patients with a prolonged QT interval were judged by the physician as worthy of follow-up. We excluded any patients in whom the physician denied the possibility of LQTS and judged no necessity for follow-up. Third, the assessments were performed at various ages and during differing follow-up periods. Nevertheless, this study yielded important findings about school-aged children with b-lqt. Conclusions The LQTS score is a reasonable method of evaluating school-aged children with b-lqt, and patients with a low LQTS score appear to be at lower risk of cardiac events. However, the examination of the LQTS score is not perfect, and the LQTS score can change during the follow-up. It is difficult to identify LQTS from b-lqt by a 1-point observation. Therefore, when there is doubt or concern regarding patients with b-lqt, it is preferable to continue following them. Guidelines are needed for follow-up strategies in patients with b-lqt based on prospective studies involving larger numbers of patients. None declared. Conflicts of Interest Acknowledgments We express our gratitude to Mr. John Martin for his assistance in preparing the manuscript. Grants This work was partly supported by the Research Grant for Cardiovascular Diseases (H26-040) from the Ministry of Health, Labour and Welfare, Japan. References 1. Yoshinaga M, Kucho Y, Nishibatake M, Ogata H, Nomura Y. Probability of diagnosing long QT syndrome in children and adolescents according to the criteria of the HRS/EHRA/APHRS expert consensus statement. Eur Heart J 2016; 37: Goldenberg I, Moss AJ, Peterson DR, McNitt S, Zareba W, Andrews ML, et al. Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-qt syndrome. Circulation 2008; 117: Liu JF, Jons C, Moss AJ, McNitt S, Peterson DR, Qi M, et al. Risk factors for recurrent syncope and subsequent fatal or near-fatal events in children and adolescents with long QT syndrome. J Am Coll Cardiol 2011; 57: Viskin S. The QT interval: Too long, too short or just right. Heart Rhythm 2009; 6: Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm 2011; 8: Webster G, Berul CI. An update on channelopathies: From mechanisms to management. Circulation 2013; 127: Schwartz PJ, Crotti L. QTc behavior during exercise and genetic testing for the long-qt syndrome. Circulation 2011; 124: Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome: An update. Circulation 1993; 88: Davignon A, Rautaharju P, Boisselle E, Soumin F, Megelas M, Choquette A. Normal ECG standards for infants and children. Pediatr Cardiol 1980; 1: Hazeki D, Yoshinaga M, Takahashi H, Tanaka Y, Haraguchi Y, Abe M, et al. Cut-offs for screening prolonged QT intervals from Fridericia s formula in children and adolescents. Circ J 2010; 74: Sy RW, van der Werf C, Chattha IS, Chockalingam P, Adler A, Healey JS, et al. Derivation and validation of a simple exercisebased algorithm for prediction of genetic testing in relatives of LQTS probands. Circulation 2011; 124: Bazett HC. An analysis of the time relationships of electrocardiograms. Heart 1920; 1920: Martin AB, Perry JC, Robinson JL, Zareba W, Moss AJ, Garson A Jr. Calculation of QTc duration and variability in the presence of sinus arrhythmia. Am J Cardiol 1995; 75: Fridericia LS. Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei Herzkranken. Acta Med Scand 1920; 53: (in German). 15. Kimura H, Zhou J, Kawamura M, Itoh H, Mizusawa Y, Ding WG, et al. Phenotype variability in patients carrying KCNJ2 mutations. Circ Cardiovasc Genet 2012; 5: Taniguchi Y, Miyazaki A, Sakaguchi H, Hayama Y, Ebishima N, Negishi J, et al. Prominent QTc prolongation in a patient with a rare variant in the cardiac ryanodine receptor gene. Heart Vessels 2017; 32: Shigemizu D, Aiba T, Nakagawa H, Ozaki K, Miya F, Satake W, et al. Exome analyses of long QT syndrome reveal candidate pathogenic mutations in calmodulin-interacting genes. PLoS One 2015; 10: e Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17: Itoh H, Crotti L, Aiba T, Spazzolini C, Denjoy I, Fressart V, et al. The genetics underlying acquired long QT syndrome: Impact for genetic screening. Eur Heart J 2016; 37: Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: Document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June Heart Rhythm 2013; 10: Hayashi K, Fujino N, Uchiyama K, Ino H, Sakata K, Konno T, et al. Long QT syndrome and associated gene mutation carriers in Japanese children: Results from ECG screening examinations. Clin Sci (Lond) 2009; 117: Shimizu W, Noda T, Takaki H, Nagaya N, Satomi K, Kurita T, et al. Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome. Heart Rhythm 2004; 1: Supplementary Files Supplementary File 1 Table S1. Results of genetic testing, LQTS score, and QTc in 59 pediatric patients with a borderline long QT interval Please find supplementary file(s);

Probability of diagnosing long QT syndrome in children and adolescents according to the criteria of the HRS/EHRA/APHRS expert consensus statement

Probability of diagnosing long QT syndrome in children and adolescents according to the criteria of the HRS/EHRA/APHRS expert consensus statement European Heart Journal (2016) 37, 2490 2497 doi:10.1093/eurheartj/ehw072 CLINICAL RESEARCH Arrhythmia/electrophysiology Probability of diagnosing long QT syndrome in children and adolescents according

More information

Pronounced Shortening of QT Interval With Mexiletine Infusion Test in Patients With Type 3 Congenital Long QT Syndrome

Pronounced Shortening of QT Interval With Mexiletine Infusion Test in Patients With Type 3 Congenital Long QT Syndrome 340 FUNASAKO M et al. Circulation Journal ORIGINAL ARTICLE Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp Arrhythmia/Electrophysiology Pronounced Shortening of Interval With

More information

FANS Long QT Syndrome Investigation Protocol (including suspected mutation carriers)

FANS Long QT Syndrome Investigation Protocol (including suspected mutation carriers) Clinical Features FANS Long QT Syndrome Investigation Protocol (including suspected mutation carriers) History Syncope or presyncope compatible with ventricular tachyarrhythmia, especially relating to

More information

Syncope in patients with inherited arrhythmogenic syndromes. Is it enough to justify ICD implantation?

Syncope in patients with inherited arrhythmogenic syndromes. Is it enough to justify ICD implantation? Innovations in Interventional Cardiology and Electrophysiology Thessaloniki 2014 Syncope in patients with inherited arrhythmogenic syndromes. Is it enough to justify ICD implantation? K. Letsas, MD, FESC

More information

Stage I: Binning Dashboard

Stage I: Binning Dashboard Stage I: Binning Dashboard P[ GENE/GENE PANEL: KCNQ1, KCNH2, SCN5A DISORDER: Romano-Ward Long QT Syndrome HGNC ID: 6294, 6251, 10593 OMIM ID: 192500, 613688, 603830 ACTIONABILITY PENETRANCE 1. Is there

More information

Long Q. Long QT Syndrome. A Guide for

Long Q. Long QT Syndrome. A Guide for Long Q Long QT Syndrome A Guide for Introduction Long QT syndrome (LQTS) is a genetic heart disorder due to the malfunction of cardiac ion channels that results in 4,000 deaths annually in the United States

More information

Asymptomatic Long QT. Prof. Dr. Martin Borggrefe Mannheim

Asymptomatic Long QT. Prof. Dr. Martin Borggrefe Mannheim Asymptomatic Long QT Prof. Dr. Martin Borggrefe Mannheim QT interval Distribution of QTc intervals in large population-based studies Viskin S, Heart Rhythm 2009; 6: 711-715 QT interval Distribution of

More information

Short-QT syndrome (SQTS) is a rare inherited disorder

Short-QT syndrome (SQTS) is a rare inherited disorder Circ J doi: 10.1253/circj.CJ-18-0213 Advance Publication by-j-stage ORIGINAL ARTICLE Pediatric Cardiology and Adult Congenital Heart Disease Tentative Screening Criteria for Short QT Interval in Children

More information

Long QT Syndrome in Children in the Era of Implantable Defibrillators

Long QT Syndrome in Children in the Era of Implantable Defibrillators Journal of the American College of Cardiology Vol. 50, No. 14, 2007 2007 by the American College of Cardiology Foundation ISSN 0735-1097/07/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2007.05.042

More information

Long-QT Syndrome After Age 40

Long-QT Syndrome After Age 40 Long-QT Syndrome After Age 40 Ilan Goldenberg, MD; Arthur J. Moss, MD; James Bradley, MS; Slava Polonsky, MS; Derick R. Peterson, PhD; Scott McNitt, MS; Wojciech Zareba, MD, PhD; Mark L. Andrews, BBA;

More information

Congenital long QT syndrome of particularly malignant course connected with so far unknown mutation in the sodium channel SCN5A gene

Congenital long QT syndrome of particularly malignant course connected with so far unknown mutation in the sodium channel SCN5A gene CASE REPORT Cardiology Journal 2013, Vol. 20, No. 1, pp. 78 82 10.5603/CJ.2013.0012 Copyright 2013 Via Medica ISSN 1897 5593 Congenital long QT syndrome of particularly malignant course connected with

More information

Risk for Life-Threatening Cardiac Events in Patients With Genotype-Confirmed Long-QT Syndrome and Normal-Range Corrected QT Intervals

Risk for Life-Threatening Cardiac Events in Patients With Genotype-Confirmed Long-QT Syndrome and Normal-Range Corrected QT Intervals Journal of the American College of Cardiology Vol. 57, No. 1, 2011 2011 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2010.07.038

More information

Differential Diagnosis Between Catecholaminergic Polymorphic Ventricular Tachycardia and Long QT Syndrome Type 1. Modified Schwartz Score

Differential Diagnosis Between Catecholaminergic Polymorphic Ventricular Tachycardia and Long QT Syndrome Type 1. Modified Schwartz Score Circ J 2018; 82: 2269 2276 doi: 10.1253/circj.CJ-17-1032 ORIGINAL ARTICLE Arrhythmia/Electrophysiology Differential Diagnosis Between Catecholaminergic Polymorphic Ventricular Tachycardia and Long QT Syndrome

More information

Pediatric Cohort With Long QT Syndrome

Pediatric Cohort With Long QT Syndrome 696 OZAWA J et al. Circulation Journal ORIGINAL ARTICLE Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp Pediatric Cardiology and Adult Congenital Heart Disease Pediatric Cohort

More information

Strength and weakness of genetic testing in clinical routine.

Strength and weakness of genetic testing in clinical routine. Strength and weakness of genetic testing in clinical routine. Silvia G Priori MD PhD Molecular Cardiology, IRCCS Fondazione Maugeri Pavia, Italy AND Leon Charney Division of Cardiology, Cardiovascular

More information

Epidemiology and clinical aspects of sudden cardiac death in the young van der Werf, C.

Epidemiology and clinical aspects of sudden cardiac death in the young van der Werf, C. UvA-DARE (Digital Academic Repository) Epidemiology and clinical aspects of sudden cardiac death in the young van der Werf, C. Link to publication Citation for published version (APA): van der Werf, C.

More information

Effect of beta-blockers on QT dynamics in the long QT syndrome: measuring the benefit

Effect of beta-blockers on QT dynamics in the long QT syndrome: measuring the benefit Europace (2014) 16, 1847 1851 doi:10.1093/europace/euu086 CLINICAL RESEARCH Channelopathies Effect of beta-blockers on QT dynamics in the long QT syndrome: measuring the benefit Matthew T. Bennett 1 *,

More information

Clinical Implications for Patients With Long QT Syndrome Who Experience a Cardiac Event During Infancy

Clinical Implications for Patients With Long QT Syndrome Who Experience a Cardiac Event During Infancy Journal of the American College of Cardiology Vol. 54, No. 9, 2009 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.05.029

More information

Update of Diagnosis and Management of Inherited Cardiac Arrhythmias

Update of Diagnosis and Management of Inherited Cardiac Arrhythmias Circulation Journal Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp REVIEW Update of Diagnosis and Management of Inherited Cardiac Arrhythmias Wataru Shimizu, MD, PhD Over

More information

The Role of Defibrillator Therapy in Genetic Arrhythmia Syndromes

The Role of Defibrillator Therapy in Genetic Arrhythmia Syndromes The Role of Defibrillator Therapy in Genetic Arrhythmia Syndromes RHEA C. PIMENTEL, MD, FACC, FHRS UNIVERSITY OF KANSAS HOSPITAL MID AMERICA CARDIOLOGY AUGUST 19, 2012 Monogenic Arrhythmia Syndromes Mendelian

More information

Pearls of the ESC/ERS Guidelines 2015 Channelopathies

Pearls of the ESC/ERS Guidelines 2015 Channelopathies Pearls of the ESC/ERS Guidelines 2015 Channelopathies Carina Blomstrom Lundqvist Dept Cardiology, Uppsala, Sweden Content 2015 ESC Guidelines for the Management of Patients with Ventricular Arrhythmias

More information

Risk for Life-Threatening Cardiac Events in Patients With Genotype-Confirmed LongQT Syndrome and Normal-Range Corrected QT Intervals

Risk for Life-Threatening Cardiac Events in Patients With Genotype-Confirmed LongQT Syndrome and Normal-Range Corrected QT Intervals Risk for Life-Threatening Cardiac Events in Patients With Genotype-Confirmed LongQT Syndrome and Normal-Range Corrected QT Intervals Goldenberg, Ilan; Horr, Samuel; Moss, Arthur J.; Lopes, Coeli M.; Barsheshet,

More information

FANS Paediatric Pathway for Inherited Arrhythmias*

FANS Paediatric Pathway for Inherited Arrhythmias* FANS Paediatric Pathway for Inherited Arrhythmias* The pathway is based on the HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes

More information

ΤΙ ΠΡΕΠΕΙ ΝΑ ΓΝΩΡΙΖΕΙ ΟΓΕΝΙΚΟΣ ΚΑΡΔΙΟΛΟΓΟΣ ΓΙΑ ΤΙΣ ΔΙΑΥΛΟΠΑΘΕΙΕΣ

ΤΙ ΠΡΕΠΕΙ ΝΑ ΓΝΩΡΙΖΕΙ ΟΓΕΝΙΚΟΣ ΚΑΡΔΙΟΛΟΓΟΣ ΓΙΑ ΤΙΣ ΔΙΑΥΛΟΠΑΘΕΙΕΣ ΤΙ ΠΡΕΠΕΙ ΝΑ ΓΝΩΡΙΖΕΙ ΟΓΕΝΙΚΟΣ ΚΑΡΔΙΟΛΟΓΟΣ ΓΙΑ ΤΙΣ ΔΙΑΥΛΟΠΑΘΕΙΕΣ ΣΤΕΛΙΟΣ ΠΑΡΑΣΚΕΥΑÏΔΗΣ ΔΙΕΥΘΥΝΤΗΣ ΕΣΥ Α Καρδιολογική Κλινική ΑΠΘ, Νοσοκομείο ΑΧΕΠΑ, Θεσσαλονίκη NO CONFLICT OF INTEREST Sudden Cardiac Death

More information

Epinephrine Unmasks Latent Mutation Carriers With LQT1 Form of Congenital Long-QT Syndrome

Epinephrine Unmasks Latent Mutation Carriers With LQT1 Form of Congenital Long-QT Syndrome Journal of the American College of Cardiology Vol. 41, No. 4, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Science Inc. doi:10.1016/s0735-1097(02)02850-4

More information

Genotype- and Mutation Site Specific QT Adaptation During Exercise, Recovery, and Postural Changes in Children With Long-QT Syndrome

Genotype- and Mutation Site Specific QT Adaptation During Exercise, Recovery, and Postural Changes in Children With Long-QT Syndrome Genotype- and Mutation Site Specific QT Adaptation During Exercise, Recovery, and Postural Changes in Children With Long-QT Syndrome Peter F. Aziz, MD; Tammy S. Wieand, MS; Jamie Ganley, RN; Jacqueline

More information

Original Articles. Utility of Treadmill Testing in Identification and Genotype Prediction in Long-QT Syndrome

Original Articles. Utility of Treadmill Testing in Identification and Genotype Prediction in Long-QT Syndrome Original Articles Utility of Treadmill Testing in Identification and Genotype Prediction in Long-QT Syndrome Jorge A. Wong, MD; Lorne J. Gula, MD; George J. Klein, MD; Raymond Yee, MD; Allan C. Skanes,

More information

When VF is the endpoint, wait and see is not always the best option.

When VF is the endpoint, wait and see is not always the best option. Being free of symptoms does not necessarily mean free of arrhythmias. This Holter is from a asymptomatic 48 years old female with LQT2 When VF is the endpoint, wait and see is not always the best option.

More information

Genotype and Mutation Site Specific QT Adaptation during Exercise, Recovery and. Postural Changes in Children with LQTS

Genotype and Mutation Site Specific QT Adaptation during Exercise, Recovery and. Postural Changes in Children with LQTS Genotype and Mutation Site Specific QT Adaptation during Exercise, Recovery and Postural Changes in Children with LQTS Running title: Aziz et al.; Exercise Stress Testing in Pediatric LQTS Patients Peter

More information

Invasive Risk Stratification: When is it needed?

Invasive Risk Stratification: When is it needed? Inherited Cardiomyopathies and Channelopathies: Who is at risk for Sudden Cardiac Death? Invasive Risk Stratification: When is it needed? Hung-Fat Tse, MD, PhD Department of Medicine The University of

More information

Medical Policy. Description/Scope. Rationale

Medical Policy. Description/Scope. Rationale Subject: Document #: Current Effective Date: 03/29/2017 Status: Reviewed Last Review Date: 02/02/2017 Description/Scope This document addresses genetic testing of cardiac ion channel mutations in persons

More information

Genetic Testing for Congenital Long QT Syndrome

Genetic Testing for Congenital Long QT Syndrome Genetic Testing for Congenital Long QT Syndrome Policy Number: 2.04.43 Last Review: 11/2013 Origination: 6/2007 Next Review: 11/2014 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide

More information

WINDLAND SMITH RICE SUDDEN DEATH GENOMICS LABORATORY

WINDLAND SMITH RICE SUDDEN DEATH GENOMICS LABORATORY Learning Objectives to Disclose: To CRITIQUE the ICD and its role in the treatment of BrS, CPVT, and LQTS WINDLAND SMITH RICE SUDDEN DEATH GENOMICS LABORATORY Conflicts of Interest to Disclose: Consultant

More information

Left cardiac sympathectomy to manage beta-blocker resistant LQT patients

Left cardiac sympathectomy to manage beta-blocker resistant LQT patients Left cardiac sympathectomy to manage beta-blocker resistant LQT patients Lexin Wang, M.D., Ph.D. Introduction Congenital long QT syndrome (LQTS) is a disorder of prolonged cardiac repolarization, manifested

More information

Are there low risk patients in Brugada syndrome?

Are there low risk patients in Brugada syndrome? Are there low risk patients in Brugada syndrome? Pedro Brugada MD, PhD Andrea Sarkozy MD Risk stratification in Brugada syndrome In the last years risk stratification in Brugada syndrome has become the

More information

Prolonged QT Syndromes: Congenital and Acquired

Prolonged QT Syndromes: Congenital and Acquired Prolonged QT Syndromes: Congenital and Acquired April 30, 2014 Elizabeth S. Kaufman, MD I have no financial disclosures. MetroHealth Campus, Case Western Reserve University Prolonged QT Syndromes Congenital

More information

Abnormal repolarization dynamics revealed in exercise test in long QT syndrome mutation carriers with normal resting QT interval

Abnormal repolarization dynamics revealed in exercise test in long QT syndrome mutation carriers with normal resting QT interval Europace (2010) 12, 1296 1301 doi:10.1093/europace/euq184 CLINICAL RESEARCH Channelopathies Abnormal repolarization dynamics revealed in exercise test in long QT syndrome mutation carriers with normal

More information

FEP Medical Policy Manual

FEP Medical Policy Manual FEP Medical Policy Manual Effective Date: April 15, 2018 Related Policies: None Genetic Testing for Cardiac Ion Channelopathies Description Genetic testing is available for patients suspected of having

More information

Congenital long-qt syndrome (LQTS) is a genetic disorder

Congenital long-qt syndrome (LQTS) is a genetic disorder Original Article Genetic Characteristics of Children and Adolescents With Long-QT Syndrome Diagnosed by School-Based Electrocardiographic Screening Programs Masao Yoshinaga, MD, PhD; Yu Kucho, MD; Jav

More information

HEIKKI SWAN, MD, KIRSI SAARINEN, MSC, KIMMO KONTULA, MD, LAURI TOIVONEN, MD, MATTI VIITASALO, MD

HEIKKI SWAN, MD, KIRSI SAARINEN, MSC, KIMMO KONTULA, MD, LAURI TOIVONEN, MD, MATTI VIITASALO, MD 486 Evaluation of QT Interval Duration and Dispersion and Proposed Clinical Criteria in Diagnosis of Long QT Syndrome in Patients With a Genetically Uniform Type of LQT1 HEIKKI SWAN, MD, KIRSI SAARINEN,

More information

Active Cascade Screening in Primary Inherited Arrhythmia Syndromes

Active Cascade Screening in Primary Inherited Arrhythmia Syndromes Journal of the American College of Cardiology Vol. 55, No. 23, 2010 2010 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.12.063

More information

Variants of Brugada Syndrome: the evolving picture

Variants of Brugada Syndrome: the evolving picture 2015 Venice Arrhythmia Core Curriculum: Arrhythmogenic genetic syndrome: what s new? Brugada Syndrome: What s new? October 16 th, 2015 Venice, Italy Variants of Brugada Syndrome: the evolving picture Wataru

More information

How to manage a patient with short QT syndrome?

How to manage a patient with short QT syndrome? How to manage a patient with short QT syndrome? Torino, 27 ottobre2012 Carla Giustetto Division of Cardiology University of Torino QT 280 ms QTc 260 ms Narrow, tall and peaked T waves High incidence of

More information

CHANNELOPATHIES IS GENETIC TESTING ESSENTIAL IN PTS MANAGEMENT

CHANNELOPATHIES IS GENETIC TESTING ESSENTIAL IN PTS MANAGEMENT CHANNELOPATHIES IS GENETIC TESTING ESSENTIAL IN PTS MANAGEMENT Inherited and Rare Cardiac Diseases Unit Heart Center for the Young and Athletes ONASSIS CARDIAC SURGERY CENTRE DIAGNOSIS ION CHANNEL DISEASE

More information

Clinical and molecular genetic risk determinants in adult long QT syndrome type 1 and 2 patients

Clinical and molecular genetic risk determinants in adult long QT syndrome type 1 and 2 patients Koponen et al. BMC Medical Genetics (2018) 19:56 https://doi.org/10.1186/s12881-018-0574-0 RESEARCH ARTICLE Open Access Clinical and molecular genetic risk determinants in adult long QT syndrome type 1

More information

ICD in a young patient with syncope

ICD in a young patient with syncope ICD in a young patient with syncope Konstantinos P. Letsas, MD, FESC Second Department of Cardiology Evangelismos General Hospital of Athens Athens, Greece Case presentation A 17-year-old apparently healthy

More information

Genetics of Sudden Cardiac Death. Geoffrey Pitt Ion Channel Research Unit Duke University. Disclosures: Grant funding from Medtronic.

Genetics of Sudden Cardiac Death. Geoffrey Pitt Ion Channel Research Unit Duke University. Disclosures: Grant funding from Medtronic. Genetics of Sudden Cardiac Death Geoffrey Pitt Ion Channel Research Unit Duke University Disclosures: Grant funding from Medtronic Duke U N I V E R S I T Y Sudden Cardiac Death High incidence 50-100 per

More information

Risk Stratification in Patients With Brugada Syndrome Without Previous Cardiac Arrest

Risk Stratification in Patients With Brugada Syndrome Without Previous Cardiac Arrest 310 OKAMURA H et al. Circulation Journal ORIGINAL ARTICLE Official Journal of the Japanese Circulation Society http://www.j-circ.or.jp Arrhythmia/Electrophysiology Risk Stratification in Patients With

More information

Is There a Genomic Basis to Acquired Channelopathic disease

Is There a Genomic Basis to Acquired Channelopathic disease Is There a Genomic Basis to Acquired Channelopathic disease Yaniv Bar-Cohen, M.D. Associate Professor of Pediatrics Division of Cardiology / Electrophysiology Children s Hospital Los Angeles Keck School

More information

Accepted Manuscript. Eiichiro Nakagawa, M.D., Ph.D., Takahiko Naruko, M.D., Ph.D., Tosinori Makita, M.D., Ph.D

Accepted Manuscript. Eiichiro Nakagawa, M.D., Ph.D., Takahiko Naruko, M.D., Ph.D., Tosinori Makita, M.D., Ph.D Accepted Manuscript Reproducibility and diagnostic usefulness of repeated sodium channel blocker test at higher precordial ECG recording in a patient with Brugada syndrome Eiichiro Nakagawa, M.D., Ph.D.,

More information

State of the Molecular Autopsy

State of the Molecular Autopsy State of the Molecular Autopsy Michael J. Ackerman, MD, PhD Windland Smith Rice Cardiovascular Genomics Research Professor Professor of Medicine, Pediatrics, and Pharmacology Director, Long QT Syndrome/Genetic

More information

Long QT Syndrome in Neonates Conduction Disorders Associated With HERG Mutations and Sinus Bradycardia With KCNQ1 Mutations

Long QT Syndrome in Neonates Conduction Disorders Associated With HERG Mutations and Sinus Bradycardia With KCNQ1 Mutations Journal of the American College of Cardiology Vol. 43, No. 5, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2003.09.049

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Genetic Testing for Cardiac Ion Channelopathies File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_cardiac_ion_channelopathies 10/2008 4/2018

More information

Case Demonstrations in Congenital and Acquired Long QT Syndrome

Case Demonstrations in Congenital and Acquired Long QT Syndrome Case Demonstrations in Congenital and Acquired Long QT Syndrome Can You Make A Correct ECG Interpretation? Li Zhang, MD; 1-2 G. Michael Vincent, MD 1 1. LQTS Studies, Department t of Medicine i LDS Hospital,

More information

Effectiveness and Limitations of -Blocker Therapy in Congenital Long-QT Syndrome

Effectiveness and Limitations of -Blocker Therapy in Congenital Long-QT Syndrome Effectiveness and Limitations of -Blocker Therapy in Congenital Long-QT Syndrome Arthur J. Moss, MD; Wojciech Zareba, MD, PhD; W. Jackson Hall, PhD; Peter J. Schwartz, MD; Richard S. Crampton, MD; Jesaia

More information

Journal of the American College of Cardiology Vol. 47, No. 1, by the American College of Cardiology Foundation ISSN /06/$32.

Journal of the American College of Cardiology Vol. 47, No. 1, by the American College of Cardiology Foundation ISSN /06/$32. Journal of the American College of Cardiology Vol. 47, No. 1, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.07.068

More information

Exercise guidelines in athletes with isolated repolarisation abnormalities and structurally normal heart.

Exercise guidelines in athletes with isolated repolarisation abnormalities and structurally normal heart. Exercise guidelines in athletes with isolated repolarisation abnormalities and structurally normal heart. Hanne Rasmusen Consultant cardiologist, PhD Dept. of Cardiology Bispebjerg University Hospital

More information

The State of the Molecular Autopsy for Sudden Death in the Young

The State of the Molecular Autopsy for Sudden Death in the Young The State of the Molecular Autopsy for Sudden Death in the Young Michael J. Ackerman, MD, PhD Windland Smith Rice Cardiovascular Genomics Research Professor Professor of Medicine, Pediatrics, and Pharmacology

More information

PAEDIATRIC ACUTE CARE GUIDELINE. ECG Interpretation

PAEDIATRIC ACUTE CARE GUIDELINE. ECG Interpretation Princess Margaret Hospital for Children PAEDIATRIC ACUTE CARE GUIDELINE ECG Interpretation Scope (Staff): Scope (Area): All Emergency Department Clinicians Emergency Department This document should be

More information

Primary Therapy for High Risk LQT Patients Should Be an ICD

Primary Therapy for High Risk LQT Patients Should Be an ICD Primary Therapy for High Risk LQT Patients Should Be an ICD Raul Weiss MD, FAHA, FACC, FHRS, CCDS Director, Electrophysiology Fellowship Program Associate Professor of Medicine The Ohio State University

More information

CONGENITAL LONG QT SYNDROME(CLQTS) ASSOCIATED WITH COMPLETE ATRIOVENTRICULAR BLOCK. A CASE REPORT.

CONGENITAL LONG QT SYNDROME(CLQTS) ASSOCIATED WITH COMPLETE ATRIOVENTRICULAR BLOCK. A CASE REPORT. CONGENITAL LONG QT SYNDROME(CLQTS) ASSOCIATED WITH COMPLETE ATRIOVENTRICULAR BLOCK. A CASE REPORT. SAHA Annual Congress 2017. Samkelo Jiyana, Adele Greyling, Andile Nxele, ZM,Makrexeni,L.Pepeta. BACKGROUND

More information

Tailored therapy in long QT syndrome

Tailored therapy in long QT syndrome Tailored therapy in long QT syndrome Dominic Abrams St. Bartholomew s & Great Ormond Street Hospitals London, UK Disclosures None Tailored therapy in long QTS Which patients should have tailored therapy...?...

More information

Risk of Aborted Cardiac Arrest or Sudden Cardiac Death During Adolescence in the Long-QT Syndrome JAMA. 2006;296:

Risk of Aborted Cardiac Arrest or Sudden Cardiac Death During Adolescence in the Long-QT Syndrome JAMA. 2006;296: ORIGINAL CONTRIBUTION Risk of Aborted Cardiac Arrest or Sudden Cardiac Death During Adolescence in the Long-QT Syndrome Jenny B. Hobbs, MD Derick R. Peterson, PhD Arthur J. Moss, MD Scott McNitt, MS Wojciech

More information

Clinical Policy Title: Genetic testing for long QT syndrome (LQTS)

Clinical Policy Title: Genetic testing for long QT syndrome (LQTS) Clinical Policy Title: Genetic testing for long QT syndrome (LQTS) Clinical Policy Number: 04.01.02 Effective Date: Dec. 1, 2013 Initial Review Date: June 19, 2013 Most Recent Review Date: July 19, 2017

More information

Death after Syncope: Can we predict it? Daniel Zamarripa, MD Senior Medical Director December 2013

Death after Syncope: Can we predict it? Daniel Zamarripa, MD Senior Medical Director December 2013 Death after Syncope: Can we predict it? Daniel Zamarripa, MD Senior Medical Director December 2013 Death after Syncope: Can we predict it? Those who suffer from frequent and severe fainting often die suddenly

More information

Professor Eric Schulze-Bahr

Professor Eric Schulze-Bahr No CoI. Professor Eric Schulze-Bahr Institute for Genetics of Heart Diseases Department of Cardiology and Angiology University Hospital Münster / Germany ICD therapy in asymptomatic or borderline LQTS

More information

Genetic testing in Cardiomyopathies

Genetic testing in Cardiomyopathies Genetic testing in Cardiomyopathies Silvia Giuliana Priori Cardiovascular Genetics, Langone Medical Center, New York University School of Medicine, New York, USA and Molecular Cardiology, IRCCS Fondazione

More information

Quinidine for Brugada syndrome: Panacea or poison?

Quinidine for Brugada syndrome: Panacea or poison? Quinidine for Brugada syndrome: Panacea or poison? Jo-Jo Hai, MBBS, * Chun-Ka Wong, MBBS, * Pak-Hei Chan, MBBS, * Hung-Fat Tse, MD, PhD, * Tak-Cheung Yung, MBBS, Chung-Wah Siu, MD From the * Division of

More information

P. Brugada 1, R. Brugada 2 and J. Brugada 3. Introduction. U.S.A.; 3 Unitat d Arritmias, Hospital Clinic, Barcelona, Spain

P. Brugada 1, R. Brugada 2 and J. Brugada 3. Introduction. U.S.A.; 3 Unitat d Arritmias, Hospital Clinic, Barcelona, Spain European Heart Journal (2000) 21, 321 326 Article No. euhj.1999.1751, available online at http://www.idealibrary.com on Sudden death in patients and relatives with the syndrome of right bundle branch block,

More information

Arrhythmia/Electrophysiology. Risk Factors for Aborted Cardiac Arrest and Sudden Cardiac Death in Children With the Congenital Long-QT Syndrome

Arrhythmia/Electrophysiology. Risk Factors for Aborted Cardiac Arrest and Sudden Cardiac Death in Children With the Congenital Long-QT Syndrome Arrhythmia/Electrophysiology Risk Factors for Aborted Cardiac Arrest and Sudden Cardiac Death in Children With the Congenital Long-QT Syndrome Ilan Goldenberg, MD; Arthur J. Moss, MD; Derick R. Peterson,

More information

QUESTION: In a patient with different QT intervals, which one will give the highest prognostic accuracy? REPLY:

QUESTION: In a patient with different QT intervals, which one will give the highest prognostic accuracy? REPLY: QUESTION: In a patient with different QT intervals, which one will give the highest prognostic accuracy? REPLY: First, there are two possibilities: I) It is not known, if the patient (subject) presented

More information

What is New in CPVT? Diagnosis Genetics Arrhythmia Mechanism Treatment. Andreas Pflaumer

What is New in CPVT? Diagnosis Genetics Arrhythmia Mechanism Treatment. Andreas Pflaumer What is New in CPVT? Diagnosis Genetics Arrhythmia Mechanism Treatment Andreas Pflaumer Diagnosis of CPVT Induction of different types of VES or VT by exercise or catecholamines AND exclusion of of other

More information

Adult Complexities of the Channelopathies

Adult Complexities of the Channelopathies Adult Complexities of the Channelopathies Andrew Krahn MD FHRS Sauder Family and Heart and Stroke Foundation Chair in Cardiology Paul Brunes Chair in Heart Rhythm Disorders University of British Columbia

More information

Further insights into inheritable arrhythmia syndromes: Focus on electrocardiograms Postema, P.G.

Further insights into inheritable arrhythmia syndromes: Focus on electrocardiograms Postema, P.G. UvA-DARE (Digital Academic Repository) Further insights into inheritable arrhythmia syndromes: Focus on electrocardiograms Postema, P.G. Link to publication Citation for published version (APA): Postema,

More information

Anton Jervell and Fred Lange-Nielsen. Evaluation and Management of Athletes With Long QT Syndrome: An Evolved Paradigm.

Anton Jervell and Fred Lange-Nielsen. Evaluation and Management of Athletes With Long QT Syndrome: An Evolved Paradigm. 660294SPHXXX10.1177/1941738116660294Gomez et al research-article2016 vol. 8 no. 6 [ Primary Care ] Evaluation and Management of Athletes With Long QT Syndrome: An Evolved Paradigm Andrew T. Gomez, MD,*

More information

Successful prenatal management of ventricular tachycardia and second-degree atrioventricular block in fetal long QT syndrome

Successful prenatal management of ventricular tachycardia and second-degree atrioventricular block in fetal long QT syndrome Successful prenatal management of ventricular tachycardia and second-degree atrioventricular block in fetal long QT syndrome Akira Miyake, MD, * Heima Sakaguchi, MD, * Aya Miyazaki, MD, * Takekazu Miyoshi,

More information

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association

Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association Genetic Testing for Page 1 of 23 Medical Policy An Independent Licensee of the Blue Cross and Blue Shield Association Title: Genetic Testing for Professional Institutional Original Effective Date: August

More information

3/17/2014. NCDR-14 ICD Registry WS # 24 Case Scenarios Including Syndromes w/ Risk of Sudden Death. Objectives

3/17/2014. NCDR-14 ICD Registry WS # 24 Case Scenarios Including Syndromes w/ Risk of Sudden Death. Objectives NCDR-14 ICD Registry WS # 24 Case Scenarios Including Syndromes w/ Risk of Sudden Death Denise Pond BSN, RN The following relationships exist related to this presentation: No Disclosures Objectives Discuss

More information

JERVELL AND LANGE-NIELSEN SYNDROME IN DEAF SCHOOL CHILDREN POPULATION

JERVELL AND LANGE-NIELSEN SYNDROME IN DEAF SCHOOL CHILDREN POPULATION ORIGINAL ARTICLE JERVELL AND LANGE-NIELSEN SYNDROME IN DEAF SCHOOL CHILDREN POPULATION Huma Farrukh 1, Arshad Khushdil 2, Farrukh Saleem 3, Azra Ehsan 4 ABSTRACT Objective: To identify the patients of

More information

Genetic Testing for Cardiac Ion Channelopathies

Genetic Testing for Cardiac Ion Channelopathies Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided

More information

Asaad Khoury 2,3 MD, Monther Boulos 1,3 MD, Mahmoud Suleiman 1,3 MD, Miry Blich 1,3 MD, Michael Eldar 4 MD, Ibrahim Marai 1,3 MD,

Asaad Khoury 2,3 MD, Monther Boulos 1,3 MD, Mahmoud Suleiman 1,3 MD, Miry Blich 1,3 MD, Michael Eldar 4 MD, Ibrahim Marai 1,3 MD, Flecainide therapy suppresses exercise induced ventricular arrhythmias in patients with CASQ2 associated catecholaminergic polymorphic ventricular tachycardia Asaad Khoury 2,3 MD, Monther Boulos 1,3 MD,

More information

Section: Effective Date: Subsection: Original Policy Date: Subject: Page: Last Review Status/Date: Background

Section: Effective Date: Subsection: Original Policy Date: Subject: Page: Last Review Status/Date: Background Genetic Testing for Cardiac Ion Last Review Status/Date: March 2014 Genetic Testing for Cardiac Ion Description Page: 1 of 22 Genetic testing is available for patients suspected of having cardiac ion channelopathies

More information

Genetic Testing for Cardiac Ion Channelopathies

Genetic Testing for Cardiac Ion Channelopathies Genetic Testing for Cardiac Ion Channelopathies Policy Number: 2.04.43 Last Review: 11/2018 Origination: 6/2007 Next Review: 11/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide

More information

Clinical Policy Title: Genetic testing for long QT syndrome (LQTS)

Clinical Policy Title: Genetic testing for long QT syndrome (LQTS) Clinical Policy Title: Genetic testing for long QT syndrome (LQTS) Clinical Policy Number: 04.01.02 Effective Date: Dec. 1, 2013 Initial Review Date: June 19, 2013 Most Recent Review Date: July 20, 2016

More information

Large Deletion in KCNQ1 Identified in a Family with Jervell and Lange-Nielsen Syndrome

Large Deletion in KCNQ1 Identified in a Family with Jervell and Lange-Nielsen Syndrome Case Report Diagnostic Genetics Ann Lab Med 2014;34:395-399 http://dx.doi.org/10.3343/alm.2014.34.5.395 ISSN 2234-3806 eissn 2234-3814 Large Deletion in KCNQ1 Identified in a Family with Jervell and Lange-Nielsen

More information

Protocol. Genetic Testing for Cardiac Ion Channelopathies

Protocol. Genetic Testing for Cardiac Ion Channelopathies Protocol Genetic Testing for Cardiac Ion Channelopathies (20443) Medical Benefit Effective Date: 04/0/8 Next Review Date: /8 Preauthorization Yes Review Dates: 05/09, 05/0, 03/, 03/2, 03/3, 03/4, 03/5,

More information

Brugada Syndrome: An Update

Brugada Syndrome: An Update Brugada Syndrome: An Update Osama Diab Associate professor of Cardiology Ain Shams university, Cairo, Egypt Updates Mechanism and Genetics Risk stratification Treatment 1 Brugada syndrome causes 4 12%

More information

Unexplained Sudden Cardiac Death in Saudi Arabia. Klinische Genetica

Unexplained Sudden Cardiac Death in Saudi Arabia. Klinische Genetica Unexplained Sudden Cardiac Death in Saudi Arabia Sudden Unexplained Death Boy: 1 year Girl: 1 and ½ year Girl: 16 year Boy: 26 year Boy: 16 year Family A and B: Referred by Dr. Tarek Momenah, PSCC Family

More information

Hereditary Cardiovascular Conditions. genetic testing for undiagnosed diseases

Hereditary Cardiovascular Conditions. genetic testing for undiagnosed diseases Hereditary Cardiovascular Conditions genetic testing for undiagnosed diseases What is Hypertrophic Cardiomyopathy (HCM)? normal heart heart with hcm Extra or thick heart muscle Typically in the left ventricle

More information

A quantitative assessment of T-wave morphology in LQT1, LQT2, and healthy individuals based on Holter recording technology

A quantitative assessment of T-wave morphology in LQT1, LQT2, and healthy individuals based on Holter recording technology A quantitative assessment of T-wave morphology in LQT1, LQT2, and healthy individuals based on Holter recording technology Martino Vaglio, MS, Jean-Philippe Couderc, PhD, MBA, Scott McNitt, MS, Xiaojuan

More information

The congenital long-qt syndrome (LQTS) is an inherited

The congenital long-qt syndrome (LQTS) is an inherited Clinical Implications for Affected arents and Siblings of robands With Long-QT Syndrome John Kimbrough, MD, hd; Arthur J. Moss, MD; Wojciech Zareba, MD, hd; Jennifer L. Robinson, MS; W. Jackson Hall, hd;

More information

Pre-Participation Athletic Cardiac Screening

Pre-Participation Athletic Cardiac Screening Pre-Participation Athletic Cardiac Screening Kimberly A Krabill, MD Pediatric and Fetal Cardiologist Northwest Congenital Heart Care, Division of MedNax Cardiology Update for Primary Care Symposium July

More information

Long QT syndrome diagnosed in the postpartum period (RCD code: VII-V-1A.2)

Long QT syndrome diagnosed in the postpartum period (RCD code: VII-V-1A.2) Journal of Rare Cardiovascular Diseases 2014; 1 (6): 15 20 www.jrcd.eu CASE REPORTS Cardiovascular diseases in pregnancy Long QT syndrome diagnosed in the postpartum period (RCD code: VII-V-1A.2) Piotr

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Genetic Testing for Predisposition to Inherited Hypertrophic File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_predisposition_to_inherited_hypertrophic_cardiomyopathy

More information

The impact of clinical and genetic findings on the management of young Brugada Syndrome patients

The impact of clinical and genetic findings on the management of young Brugada Syndrome patients 12 ème Congrès Médico-Chirugical de la FCPC 21 au 24 novembre 2015 Schoelcher, Martinique The impact of clinical and genetic findings on the management of young Brugada Syndrome patients Institut du Thorax,

More information

Management of Arrhythmia Syndromes in the Newborn and Very Young Child: Unique Risks & Barriers in this Age Population

Management of Arrhythmia Syndromes in the Newborn and Very Young Child: Unique Risks & Barriers in this Age Population Management of Arrhythmia Syndromes in the Newborn and Very Young Child: Unique Risks & Barriers in this Age Population Mitchell Cohen, MD FACC FHRS Co-Director Heart Center Chief of Pediatric Cardiology

More information